Our technologies
At Bristol Myers Squibb, we are utilizing innovative technologies to accelerate every aspect of our business.
At BMS, we are unleashing the power of digital technologies to advance our mission and vision to transform patients’ lives through science and get more medicines to more patients faster, in ways that enhance outcomes. We’re putting technology at the service of our talented professionals in every facet of our organization, helping each of our 34,000+ employees do their best work every day. Technology makes us more productive, agile and efficient through every stage of our work, from early research and discovery to drug development, manufacturing, supply chain and commercialization.
Pioneering the future of medicine
“We want to accelerate our pipeline to deliver transformational medicines to patients around the globe. Pairing cutting-edge research and technology with our unmatched understanding of causal human biology, we aim to provide the best outcomes possible for patients today and in the future.”
Robert Plenge, Executive Vice President, Chief Research Officer, Head of Research
“The state of artificial intelligence and machine learning is similar to where we were with personal computers in the 1980’s” — we are just getting started and there is so much more to discover. Technology and digital capabilities are reshaping our work – from how we develop medicines, to how we run our core business operations, all in service to patients everywhere.”
Greg Meyers, Executive Vice President, Chief Digital & Technology Officer
Explore the ways we are accelerating innovation
R&D predictive technologies
At Bristol Myers Squibb, we embrace AI and data-driven decision-making across the entire R&D continuum, focusing on telling the full story from discovery to patient impact. Artificial intelligence and machine learning have become indispensable accelerators of R&D, advancing the path from laboratory discoveries to patient care at the bedside. By combining AI and machine learning with a humanistic approach to research, we’re able to harness the potential of early scientific discoveries and drive efficiencies in later stages of development, ultimately making breakthroughs more accessible to the patients who need them.
Digital health
At Bristol Myers Squibb, our digital health technologies are helping create a step change in how health conditions are diagnosed, treated, and monitored. From wearable biosensors to patient companion apps, we’re building a future where digital solutions work alongside our medicines to deliver more precise, proactive care. We’re also transforming how we engage with clinicians, using our technologies to equip them with timely insights and decision-support tools that enhance care delivery. With over two dozen AI-enabled digital health tools in development, we’re committed to a future where patients have greater agency, better access to health information, and more collaborative conversations with providers about treatment and care decisions.
Artificial intelligence & machine learning
By uniting the expertise of our scientists, researchers, clinicians and engineers with the power of computer and data science, artificial intelligence (AI) and machine learning (ML), we’re accelerating discovery and transforming the way we work. This fusion of human ingenuity and advanced technology strengthens our ability to uncover insights faster, design smarter trials and deliver new solutions with greater precision — bringing together world-class science and innovative technology to drive meaningful progress for patients.
Join us as we transform patients live through science
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. As global citizens, we work sustainably and responsibly to create a positive impact in the communities where we live and work.
